alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**EXHIBIT 31.1**

 

**CERTIFICATION OF PERIODIC REPORT UNDER SECTION 302 OF**

**THE SARBANES-OXLEY ACT OF 2002**

 

I, Umang Gupta, certify that: 

 

1. I have reviewed this quarterly report on Form 10-Q of Keynote Systems, Inc.; 

 

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statementsmade, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report; 

 

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects thefinancial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report; 

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange ActRules 13a-15(e) and 15d-15(e)) for the registrant and have: 

 

a) Designed suchdisclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to usby others within those entities, particularly during the period in which this quarterly report is being prepared; 

 

b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

 

c) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscalquarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to theregistrant’s auditors and the audit committee of the registrant’s board of directors: 

 

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record,process, summarize and report financial information; and 

 

b) Any fraud, whetheror not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. 

 

Date: February 10, 2004
EXHIBIT 10(aa)
                         AMENDMENT NO. 1


         Pursuant to Section 14 of that certain Employment
Agreement by and between Blount International, Inc. ("Company")
and Richard H. Irving III ("Executive") dated as of the 15th day
of May, 1995 ("Agreement"), the parties hereby amend and modify
such Agreement ("Amendment No. 1") and agree that effective from
and after this 1st day of November, 1998:
         In order better to reflect the terms and conditions of
comparable agreements, and in recognition of Executive's
contribution to the Company, the "eighteen (18) month" references
at Sections 5.1, 5.1(a), 5.1(b), 5.1(c), 5.1(d)(both references),
5.1(e), 5.1(g), 5.1(h), 5.1(i) and 5.4(a) shall be amended and
modified to read, "twenty-four (24) months."
         IN WITNESS WHEREOF, the parties have executed this
Amendment No. 1 as of the day and year first above written.
                                 EXECUTIVE:


                                 _____________________________
                                 RICHARD H. IRVING III
                                 Senior Vice President and
                                 General Counsel


                                 COMPANY:

                                 BLOUNT INTERNATIONAL, INC.
         

                                 By: ___________________________
                                 JOHN M. PANETTIERE
                                 President 
                                 & Chief Executive Officer
          
Witness:_____________________



_____________________________
Notary Public
<PAGE>
Exhibit 32.2



PERICOM SEMICONDUCTOR CORPORATION



CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with this annual report of Pericom Semiconductor Corporation (the
Company) on Form 10-K for the year ended June 29, 2003 (the Report), I, Michael D. Craighead, Chief Financial Officer of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section
1350 of the United States Code, that to the best of my knowledge:



(1) the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and



(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at
the dates and for the periods indicated.



September 26, 2003



By:

/s/    MICHAEL D.
CRAIGHEADMichael D. Craighead Chief Financial Officer Pericom Semiconductor Corporation
<Page>

                                                                    EXHIBIT 99.2

            CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of PRAECIS PHARMACEUTICALS
INCORPORATED (the "Company") for the quarterly period ended September 30, 2002
as filed with the Securities and Exchange Commission on the date hereof (the
"Report"), I, Kevin F. McLaughlin, as Chief Financial Officer of the Company,
hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my
knowledge:

     1. The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

     2. The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.

    /s/ Kevin F. McLaughlin
----------------------------------------
Name:   Kevin F. McLaughlin
Title:  Chief Financial Officer
Date:   November 13, 2002

This certification accompanies the Report pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the
Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended.
----

----

| (1) | The                  Report fully complies with the requirements of Section 13(a){15(d)}                  of the                  Securities Exchange Act of 1934, as amended;                  and |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2) | The                  information contained in the Report fairly presents, in all material                  respects, the financial condition and results of operations of                  the                  Registrant. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Dated:                  January 13, 2006 | /s/                  WILLIAM H.                  CAMPBELL                                                   |
|------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                     | William                  H. Campbell                                                                                                                                                                                                                                                                                                                                  |
|                                     | Executive                  Vice President, Chief Financial                  Officer                                                                                                                                                                                                                                                                                   |

----
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of the Treasury

###### Internal Revenue Service

# AGENCY:

Internal Revenue Service (IRS), Treasury.

# ACTION:

Notice of meeting.

# SUMMARY:

An open meeting of the Taxpayer Advocacy Panel Joint Committee will be conducted. The Taxpayer Advocacy Panel is soliciting public comments, ideas, and suggestions on improving customer service at the Internal Revenue Service.

# DATES:

The meeting will be held Tuesday, August 24, 2021 and Wednesday, August 25, 2021.

# FOR FURTHER INFORMATION CONTACT:

Gilbert Martinez at 1-888-912-1227 or (737) 800-4060.

# SUPPLEMENTARY INFORMATION:

Notice is hereby given pursuant to Section 10(a)(2) of the Federal Advisory Committee Act, 5 U.S.C. App. (1988) that an open meeting of the Taxpayer Advocacy Panel Joint Committee will be held Tuesday, August 24, 2021, from 1:30pm to 3:30pm Eastern Time and Wednesday, August 25, 2021, from 1:30pm to 3:30pm Eastern Time. The public is invited to make oral comments or submit written statements for consideration. For more information please contact Gilbert Martinez at 1-888-912-1227 or (737-800-4060), or write TAP Office 3651 S. IH-35, STOP 1005 AUSC, Austin, TX 78741, or post comments to the website: *http://www.improveirs.org.*

The agenda will include various committee issues for submission to the       ( print page 42015)    IRS and other TAP related topics. Public input is welcomed.

Dated: July 30, 2021.

Kevin Brown,

Acting Director, Taxpayer Advocacy Panel.

[FR Doc. 2021-16640 Filed 8-3-21; 8:45 am]

BILLING CODE 4830-01-P
S. 1298

One Hundred Fifth Congress

of the

United States of America

AT THE SECOND SESSION

Begun and held at the City of Washington on Tuesday,

the twenty-seventh day of January, one thousand nine hundred and ninety-eight

An Act

To designate a Federal building located in Florence, Alabama, as the ‘‘Justice

John McKinley Federal Building’’.

Be it enacted by the Senate and House of Representatives of

the United States of America in Congress assembled,

SECTION 1. DESIGNATION OF JUSTICE JOHN MCKINLEY FEDERAL

BUILDING.

The Federal building located at 210 North Seminary Street

in Florence, Alabama, shall be known and designated as the ‘‘Justice

John McKinley Federal Building’’.

SEC. 2. REFERENCES.

Any reference in a law, map, regulation, document, paper,

or other record of the United States to the Federal building referred

to in section 1 shall be deemed to be a reference to the ‘‘Justice

John McKinley Federal Building’’.

Speaker of the House of Representatives.

Vice President of the United States and

President of the Senate.
105TH CONGRESS

1ST SESSION S. 1266

AN ACT

To interpret the term ‘‘kidnaping’’ in extradition treaties

to which the United States is a party.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. SHORT TITLE.

4 This Act may be cited as the ‘‘Extradition Treaties

5 Interpretation Act of 1997’’.
2

S 1266 ES

1 SEC. 2. FINDINGS.

2 Congress finds that—

3 (1) each year, several hundred children are kid4 napped by a parent in violation of law, court order,

5 or legally binding agreement and brought to, or

6 taken from, the United States;

7 (2) until the mid-1970’s, parental abduction

8 generally was not considered a criminal offense in

9 the United States;

10 (3) since the mid-1970’s, United States crimi11 nal law has evolved such that parental abduction is

12 now a criminal offense in each of the 50 States and

13 the District of Columbia;

14 (4) in enacting the International Parental Kid15 napping Crime Act of 1993 (Public Law 103–173;

16 107 Stat. 1998; 18 U.S.C. 1204), Congress recog17 nized the need to combat parental abduction by

18 making the act of international parental kidnapping

19 a Federal criminal offense;

20 (5) many of the extradition treaties to which

21 the United States is a party specifically list the of22 fenses that are extraditable and use the word ‘‘kid23 napping’’, but it has been the practice of the United

24 States not to consider the term to include parental

25 abduction because these treaties were negotiated by

26 the United States prior to the development in Unit-
3

S 1266 ES

1 ed States criminal law described in paragraphs (3)

2 and (4);

3 (6) the more modern extradition treaties to

4 which the United States is a party contain dual

5 criminality provisions, which provide for extradition

6 where both parties make the offense a felony, and

7 therefore it is the practice of the United States to

8 consider such treaties to include parental abduction

9 if the other foreign state party also considers the act

10 of parental abduction to be a criminal offense; and

11 (7) this circumstance has resulted in a disparity

12 in United States extradition law which should be

13 rectified to better protect the interests of children

14 and their parents.

15 SEC. 3. INTERPRETATION OF EXTRADITION TREATIES.

16 For purposes of any extradition treaty to which the

17 United States is a party, Congress authorizes the interpre18 tation of the terms ‘‘kidnaping’’ and ‘‘kidnapping’’ to in19 clude parental kidnapping.

Passed the Senate October 23, 1997.

Attest:

Secretary.
105TH CONGRESS

1ST SESSION S. 1266

AN ACT

To interpret the term ‘‘kidnaping’’ in extradition

treaties to which the United States is a party.
Document

CERTAIN IDENTIFIED INFORMATION HAS BEEN OMITTED FROM THIS DOCUMENT BECAUSE IT IS NOT MATERIAL AND (I) WOULD BE COMPETITIVELY HARMFUL TO THE REGISTRANT IF PUBLICLY DISCLOSED OR (II) IS INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. SUCH INFORMATION HAS BEEN MARKED WITH “[***]” TO INDICATE WHERE OMISSIONS HAVE BEEN MADE.




AMENDMENT TO SECTION A OF EXHIBIT A OF THE DISTRIBUTION AGREEMENT
FOR THE [ZO MEDICAL I ZO SKIN HEALTH] PRODUCT LINE


1.    Preamble.  A  Distribution Agreement (“Agreement”) for the [ZO Medical / ZO Skin     Health] line of products was entered into by and between ZO SKIN HEALTH, INC. (“ZO SKIN HEALTH”) and Cutera, Inc. (“Distributor”)    effective as of August 5th, 2013, which is currently  in full force and effect. Under Sections 1.6, 1.8, 3.1 and 7.1 of the Agreement, ZO SKIN HEALTH
reserved the right to amend Exhibit A from time to time to reflect changes to the Products and Related Products and the prices of the Products and Related Products.  Specifically, the Products,
Related Products, if any, and corresponding prices are identified in Section A of Exhibit A of the Agreement. ZO SKIN HEALTH now wishes to amend Section A of that exhibit.
2.    Amendment to Section A of Exhibit A. ZO SKIN HEALTH hereby amends Section A of Exhibit A to reflect the Products, Related Products, if any, and prices set forth on the Revised Schedule of Products attached hereto and incorporated herein by this reference.
3.    Effective Date of Revised Schedule of Products. The revised Products, Related Products, if any, and prices set forth in the Revised Sched ule of Products [shall lake effect on / was effective as of] August 21st, 2013.
4.    Waiver of Notice and Consent. Distributor hereby waives notice of the change and consents to the Revised Schedule of Products as of the date set forth in paragraph 3 above.
ZO SKIN HEALTH, INC.



















			
	Amendment to Section A of Exhibit A of the Distribution Agreement








REVISED SCHEDULE OF PRODUCTS


Section A of Exhibit A is hereby restated as follows:


A.    PRODUCTS.


ZO SKIN HEALTH skin care products currently subject to this Distribution Agreement include:







			
	2







			
	Amendment to Section A of Exhibit A of the Distribution Agreement








REVISED SCHEDULE OF PRODUCTS


Section A of Exhibit A is hereby restated as follows:


A.    PRODUCTS.


ZO SKIN HEALTH skin care products currently subject to this Distribution Agreement include:





			
	3
COURT OF APPEALS

SECOND DISTRICT OF TEXAS

FORT WORTH

NO. 02-12-00624-CR

Tracy Wayne Parker

v.

The State of Texas

§

§

§

§

§

From the 297th District Court

of Tarrant County (0566349A)

January 16, 2014

Per Curiam

(nfp)

JUDGMENT

This court has considered the record on appeal in this case and holds that 

there was no error in the trial court’s judgment. It is ordered that the judgment of 

the trial court is affirmed.

SECOND DISTRICT COURT OF APPEALS 

PER CURIAM
Exhibit 32.1



CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of Sontra Medical Corporation (the Company) on Form 10-QSB for the period ending June 30, 2003 as
filed with the Securities and Exchange Commission on the date hereof (the Report), I, Thomas W. Davison, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906
of the Sarbanes-Oxley Act of 2002, that to my knowledge:



| | (1) |  | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- |  | ---------------------------------------------------------------------------------------------------------------------



| | (2) |  | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------



/s/    THOMAS W.
DAVISON

Thomas W. Davison

President and Chief Executive Officer



August 14, 2003



This certification accompanies the
Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as
amended.



A signed original of this written statement required
by the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
March 11, 2011











Mike Rugen


Chief Financial Officer


Tengasco, Inc.


10215 Technology Drive


Knoxville, TN 37932








RE: Authorization to cite R^2 in Tengasco’s SEC filing for 12/31/2010.











Dear Mr. Rugen,











Thank you for choosing R^2 to provide valuations for Tengasco’s portfolio of derivative hedge transactions. You have the consent of R^2 to reference our company in Tengasco’s SEC filing for the analytical work we provided as of 12/31/2010.











Sincerely,

















Wayne Penello


President


ANOVA Management, Inc.


General Partner of


Risked Revenue Energy Associates


Risked Revenue Energy Associates
 2029 Woodhead St. • Houston, Texas • 77019
 Phone: 713-522-6161 • www.riskedrevenue.com
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Poultry Research: Mississippi State, MS
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    CareersSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Southeast Area Mississippi State, Mississippi Poultry Research People & Locations







Larry  Halford
                        Poultry Research

                        




                        
                        Biological Science Technician
                        Phone: (662) 320-7604
                        
                        
                        Fax: (Employee information on this page comes from the REE Directory. Please contact your front office staff to update the REE Directory.)


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov